Although we cannot exclude the possibility that among 13 MSI tumours from our cohort without MLH1 promoter hypermethylation there may be a hidden Lynch associated tumour, the selection criteria and the relatively low percentage of true Lynch tumours among unselected CRCs [48] stand against it. The gene discussed is MLH1; the disease is neoplasm.